All the data they delivered is either insufficent or was
All the data they delivered is either insufficent or was corrupted by AMAREX and will not get us over the finishline anytime soon. But I guess you do not mind since it does not matter what happend in the past and that the SP is still in a 2017 territory with additional few hundred million shares of dilution.
It was too much to ask to focus and finish HIV first in a professional and timely manner and maybe then start to look and spend money at other indications.
Yes, a clown show like busting a possible successful P3 HIV trial beacuse of lack of (any) oversight from Cytodyn. (possible succesful since the data is in such a mess that no successful BLA can be achieved)
Clownshow like filing for a HIV BLA and not be able to recognize the shit AMAREX has created for years (even after all the hints from FDA)!
Clownshow like not be capeable of doing basic homework like cheking if AMAREX is doing its basics like gatehering safety data in an acceptable manner.
Clown show like the brazil stunt, where they belived they could run a covid trial in a forign (even more corrupt country) from distance and without sufficent money when they already messed up covid trials in the USA (age stratefication).
Clown show like starting several trials at once with insufficent money, insufficent trial sizes and beliving we would get, based on this, a three finger (digit) offer from BP.
Clown show like not be able to realize for sveral years how AMAREX has betrayed us in evry possible manner.
Clownshow like hiring Pestell, giving him 20M shares and then not moving forward for over a year with cancer indication.
Clownshow like hiring a guy like Mr. Mahboob which tells us in his first apperance how happy his kid is that he has now more time and then firing him a few month later. (btw. I guess he was innocent, since the data was so corrupted)
Clownshow like Jay Lalezary has described it in a more friendly manner ...
If this is in your opinion the way a biopharma company should be "managed" than you better check if Nader has something new cooking.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....
Continue Reading
illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....
Continue Reading
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...
Continue Reading
A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...
Continue Reading
A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...
Continue Reading
An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigation of Light & Wonder, Inc. Underway The Law Offices of Howard G. Smith is currently conducting a significant investigation concerning Light & Wonder, Inc. (NASDAQ: LNW) on behalf of its investors. This inquiry focuses on allegations regarding potential violations of federal securities laws that could have serious implications for the company's stakeholders....
Continue Reading
Anticipating Market Movements as CPI Report Approaches The excitement in the market today stems from an essential report that could influence investment patterns significantly. In particular, the Consumer Price Index (CPI) report release is generating considerable attention, coupled with a substantial Treasury settlement, which is one of three set for this week. Observers...
Continue Reading
Levi & Korsinsky Invites Novo Investors to Join Class Action Levi & Korsinsky, LLP is actively reaching out to investors of Novo Nordisk A/S to inform them about a significant class action securities lawsuit. This lawsuit is an essential step for those who have faced losses due to alleged securities fraud involving Novo, particularly during a specified timeframe....
Continue Reading
Exploring the FinTech Blockchain Market In recent years, the FinTech blockchain market has experienced impressive growth, signaling a transformative shift in financial technology. Current reports suggest that this sector is expected to grow from $2.94 billion in 2023 to $4.36 billion in 2024, which translates to a compound annual growth rate (CAGR) of 48.1%. This surge is...
Continue Reading
Covia Implements Price Increase for Industrial Products Covia, a prominent name in the industrial minerals sector, has announced an essential price increase for its diverse range of industrial products. Starting from November 1, 2024, the increase will affect non-contract customers and could reach 10% or more, depending on the specific products, grades, and manufacturing...
Continue Reading